Protek Capital Stock Performance

The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Protek Capital are completely uncorrelated.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Protek Capital has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Total Cashflows From Investing Activities-55.1 K
  

Protek Capital Relative Risk vs. Return Landscape

If you would invest  0.01  in Protek Capital on November 29, 2024 and sell it today you would lose (0.01) from holding Protek Capital or give up 100.0% of portfolio value over 90 days. Protek Capital is currently does not generate positive expected returns and assumes 13.0189% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Protek, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Protek Capital is expected to under-perform the market. In addition to that, the company is 17.79 times more volatile than its market benchmark. It trades about -0.13 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.07 per unit of volatility.

Protek Capital Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Protek Capital's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Protek Capital, and traders can use it to determine the average amount a Protek Capital's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1302

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPRPM

Estimated Market Risk

 13.02
  actual daily
96
96% of assets are less volatile

Expected Return

 -1.69
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.13
  actual daily
0
Most of other assets perform better
Based on monthly moving average Protek Capital is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protek Capital by adding Protek Capital to a well-diversified portfolio.

Protek Capital Fundamentals Growth

Protek Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Protek Capital, and Protek Capital fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Protek Pink Sheet performance.

About Protek Capital Performance

By examining Protek Capital's fundamental ratios, stakeholders can obtain critical insights into Protek Capital's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Protek Capital is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
ProTek Capital, Inc. focuses on investing or acquiring software companies that are privately held or traded on the public markets. The company was incorporated in 1995 and is based in Delray Beach, Florida. Protek Capital is traded on OTC Exchange in the United States.

Things to note about Protek Capital performance evaluation

Checking the ongoing alerts about Protek Capital for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Protek Capital help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Protek Capital generated a negative expected return over the last 90 days
Protek Capital has high historical volatility and very poor performance
Protek Capital has some characteristics of a very speculative penny stock
Protek Capital has a very high chance of going through financial distress in the upcoming years
Protek Capital currently holds 84.3 K in liabilities. Protek Capital has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Protek Capital until it has trouble settling it off, either with new capital or with free cash flow. So, Protek Capital's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Protek Capital sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Protek to invest in growth at high rates of return. When we think about Protek Capital's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (218.31 K) with profit before overhead, payroll, taxes, and interest of 11.62 K.
Evaluating Protek Capital's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Protek Capital's pink sheet performance include:
  • Analyzing Protek Capital's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Protek Capital's stock is overvalued or undervalued compared to its peers.
  • Examining Protek Capital's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Protek Capital's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Protek Capital's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Protek Capital's pink sheet. These opinions can provide insight into Protek Capital's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Protek Capital's pink sheet performance is not an exact science, and many factors can impact Protek Capital's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Other Information on Investing in Protek Pink Sheet

Protek Capital financial ratios help investors to determine whether Protek Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Protek with respect to the benefits of owning Protek Capital security.